

Midatech Pharma Gets EU Grant For Brain Cancer Drug


Armistice Capital Takes Almost 10% Interest In Midatech Pharma


Midatech Pharma Childhood Cancer Drug Given FDA Orphan Designation


Midatech Pharma Inks USD3.0 Million Registered Direct Offering Deal


Midatech Doses First Patients In MTD201 Administration Method Study


(Sharecast News) - Midatech Pharma on Tuesday announced that its MTD201 Phase 1 study for the treatment of acromegaly and neuroendocrine tumours has c...


DIRECTOR DEALINGS: Midatech Pharma CFO Buys GBP30,000 In Shares


DIRECTOR DEALINGS: Midatech Pharma CFO Stephen Stamp Buys Shares